Narufumi Suganuma Selected Research

Narufumi Suganuma Research Topics

Disease

6	Fibrosis (Cirrhosis) 09/2017 - 05/2012
5	Asthma (Bronchial Asthma) 07/2023 - 04/2010
4	Birth Weight (Birth Weights) 06/2023 - 11/2020
4	Silicosis 05/2023 - 01/2013
4	Inflammation (Inflammations) 01/2021 - 05/2012
3	Non-alcoholic Fatty Liver Disease 09/2017 - 01/2013
2	Pain (Aches) 04/2024 - 01/2022
2	Pneumoconiosis 05/2023 - 04/2015
2	Anthracosis 05/2023 - 04/2015
2	Hypersensitivity (Allergy) 01/2023 - 03/2004
2	Postpartum Depression (Post-Natal Depression) 01/2022 - 01/2022
2	Fatty Liver 12/2021 - 03/2021
2	Disease Progression 03/2021 - 01/2021
2	Lung Neoplasms (Lung Cancer) 05/2018 - 04/2015
2	Insulin Resistance 09/2017 - 01/2013
2	Lung Diseases (Lung Disease) 01/2016 - 04/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016 - 10/2008
2	Neoplasms (Cancer) 10/2015 - 04/2015
2	Respiratory Hypersensitivity 05/2012 - 08/2011
1	Breech Presentation 12/2024
1	Eczema 04/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024
1	Bronchiectasis 01/2024
1	Wounds and Injuries (Trauma) 07/2023
1	Avoidant Restrictive Food Intake Disorder 09/2022
1	Weight Gain 01/2022
1	Vomiting 01/2022
1	Nausea 01/2022
1	Respiratory Sounds (Crackle) 01/2022
1	Neurodevelopmental Disorders 11/2021
1	Acatalasia (Acatalasemia) 10/2021
1	Obesity 08/2021
1	Hepatocellular Carcinoma (Hepatoma) 08/2021
1	Atherosclerosis 08/2021
1	Alcoholic Fatty Liver 03/2021
1	Liver Diseases (Liver Disease) 02/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Anemia 11/2020
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 11/2020
1	Hypertrophy 11/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2020
1	Diabetes Mellitus 09/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2017

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 08/2021 - 08/2008
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 07/2023 - 05/2006
3	Particulate MatterIBA 07/2023 - 11/2020
2	ORALIT (ORS)IBA 12/2024 - 01/2022
2	Indicators and Reagents (Reagents)IBA 06/2023 - 10/2022
2	CholesterolIBA 06/2023 - 01/2022
2	Tuberculin (PPD)IBA 01/2022 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 11/2020 - 09/2017
2	AsbestosIBA 05/2018 - 01/2010
2	1,5-anhydroglucitolIBA 09/2017 - 01/2013
2	IndiumIBA 01/2016 - 01/2016
2	SeleniumIBA 04/2015 - 01/2013
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2013 - 10/2008
2	CytokinesIBA 05/2012 - 04/2010
2	LimoneneIBA 05/2012 - 04/2010
1	Artificial SalivaIBA 04/2024
1	InsecticidesIBA 04/2024
1	HydrogenIBA 01/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024
1	OzoneIBA 07/2023
1	Nitrogen DioxideIBA 07/2023
1	Air Pollutants (Pollutants, Air)IBA 07/2023
1	oxidized low density lipoproteinIBA 06/2023
1	GraphiteIBA 05/2023
1	Irritants (Vesicants)IBA 01/2023
1	AntibodiesIBA 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	IsocyanatesIBA 01/2023
1	N,N-di-n-propylserotonin (NDPS)IBA 09/2022
1	CotinineIBA 01/2022
1	KeroseneIBA 01/2022
1	Volatile Organic CompoundsIBA 11/2021
1	CatalaseIBA 10/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021
1	Glutamate-Cysteine LigaseIBA 10/2021
1	ArginaseIBA 08/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2021
1	Messenger RNA (mRNA)IBA 03/2021
1	Nonesterified Fatty Acids (NEFA)IBA 03/2021
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	LigandsIBA 01/2021
1	Charcoal (Charbon)IBA 11/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2017
1	Collagen Type IV (Type IV Collagen)IBA 09/2017
1	Hyaluronic Acid (Hyaluronan)IBA 09/2017
1	Insulin (Novolin)FDA Link 09/2017
1	Alanine Transaminase (SGPT)IBA 09/2017
1	Environmental Pollutants (Pollutants, Environmental)IBA 03/2017

Therapy/Procedure

4	Therapeutics 01/2021 - 08/2008
1	Traction 01/2024
1	Surgical Instruments (Clip) 07/2023
1	Suture Techniques 07/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Aftercare (After-Treatment) 08/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019